Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro-Reference-Cited by-同舟云学术

Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro

Published:2020-06 Issue: Volume:178 Page:104786
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Choy Ka-Tim,Wong Alvina Yin-Lam,Kaewpreedee Prathanporn,Sia Sin Fun,Chen Dongdong,Hui Kenrie Pui Yan,Chu Daniel Ka Wing,Chan Michael Chi Wai,Cheung Peter Pak-Hang,Huang Xuhui,Peiris Malik,Yen Hui-Ling

Funder

National Institute of Allergy and Infectious Diseases

National Institutes of Health, USA

Theme-Based Research Scheme

Research Grants Council, Hong Kong SAR, China

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference36 articles.

1. Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease;Agostini;mBio,2018

2. Novel antiviral activities of obatoclax, emetine, niclosamide, brequinar, and homoharringtonine;Andersen;Viruses,2019

3. Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase;Brown;Antivir. Res.,2019

4. A screen of the NIH Clinical Collection small molecule library identifies potential anti-coronavirus drugs;Cao;Antivir. Res.,2015

5. A trial of lopinavir-ritonavir in adults hospitalized with severe covid-19;Cao;N. Engl. J. Med.,2020

Cited by 762 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic potential of natural alkaloid emetine against emerging COVID-19 and future viral pandemics;European Journal of Medicinal Chemistry Reports;2024-12

2. Antiviral therapy for COVID-19 virus: A narrative review and bibliometric analysis;The American Journal of Emergency Medicine;2024-11

3. SARS-CoV-2 replication and drug discovery;Molecular and Cellular Probes;2024-10

4. A Gaussia luciferase reporter assay for the evaluation of coronavirus Nsp5/3CLpro activity;Scientific Reports;2024-09-05

5. Insights for Future Pharmacology: Exploring Phytochemicals as Potential Inhibitors Targeting SARS-CoV-2 Papain-like Protease;Future Pharmacology;2024-08-17